Ottawa, September 28, 2017 The following statement can be attributed to Innovative Medicines Canada’s president, Pamela Fralick: “Innovative Medicines Canada and its member companies are proud to be an integral […]
Ottawa, September 27, 2017 The following statement can be attributed to Innovative Medicines Canada’s president, Pamela Fralick: “The innovative pharmaceutical industry will review any proposed legislation with respect to disclosure […]
Ottawa, September 21, 2017 With regards to the provisional application of the Comprehensive and Economic Trade Agreement (CETA), Pamela Fralick, President, Innovative Medicines Canada issued the following statement: “Innovative Medicines […]
Ottawa, September 11, 2017 The following statement can be attributed to Innovative Medicines Canada’s president, Pamela Fralick: “Innovative Medicines Canada is supportive of the actions the federal government is taking […]
Ottawa, September 7, 2017 The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada (IMC) has supported the Comprehensive and Economic Trade Agreement (CETA) […]
Ottawa, September 5, 2017 – Building on the strengths of Canada’s life sciences sector, Innovative Medicines Canada is pleased to announce two new members: Akcea Therapeutics Canada and Ipsen Biopharmaceuticals […]
Ottawa, August 4, 2017 The following statement can be attributed to Pamela Fralick, President, Innovative Medicines Canada. “Innovative Medicines Canada and its member companies support policies and practices that place […]
This strategic partnership will identify ways to attract investment, expand research, improve patient access to medicines and, ultimately…
Innovative Medicines Canada welcomes the life sciences strategy, the positioning of Quebec and continued work to improve access to medicines for Quebec patients. Montreal, May 5, 2017 – Innovative Medicines Canada […]
Toronto, April 27, 2017 – In response to the budget tabled by Ontario Finance Minister Charles Sousa, Innovative Medicines Canada welcomes the Government of Ontario’s initiative to launch OHIP+, a […]
